Hemorrhoids Treatment Market Size Projected to Reach $1.9 billion by 2034 | 5.5%

According to Straits Research, the global hemorrhoid treatment market size was valued at $1.16 billion in 2025 and is projected to grow from $1.23 billion in 2026 to $1.94 billion by 2034 at a CAGR of 6.01% during the forecast period 2026–2034. North America accounted for the largest hemorrhoid treatment market share, with 35.11% in 2025.

Hemorrhoid treatment refers to the various medical and non-medical approaches used to manage and alleviate the symptoms of hemorrhoidal disease, a condition characterized by swollen veins in the lower rectum and anus. Treatment options range from lifestyle modifications, such as dietary changes and increased fiber intake, to over-the-counter remedies, including creams, suppositories, and sitz baths. For more severe cases, minimally invasive procedures like rubber band ligation, sclerotherapy, and infrared coagulation are effective solutions.

Market Dynamics

Rising awareness programs for hemorrhoids treatment drive the global market

Health education campaigns and awareness initiatives are playing a crucial role in promoting early diagnosis and timely treatment of hemorrhoids. As public understanding of the condition increases, so does the demand for effective and accessible treatment options.

• For example, in May 2024, the World Gastroenterology Organization launched its World Digestive Health Day campaign, highlighting the prevention and management of gastrointestinal disorders, including hemorrhoids. Such global initiatives significantly contribute to raising awareness and encouraging proactive healthcare.

With a stronger emphasis on education and prevention, the demand for hemorrhoid treatments is expected to rise, further driving market growth.

Advancement in technologies for hemorrhoid treatment creates tremendous opportunities

The continuous evolution of medical technologies is creating substantial opportunities in the global hemorrhoids treatment market. Innovations in minimally invasive procedures and advanced pharmaceutical solutions are driving demand due to their enhanced efficacy and quicker recovery periods.

• For example, in June 2023, Citius Pharmaceuticals reported positive outcomes from its Phase 2b study of Halo-Lido (CITI-002), a novel drug for hemorrhoid treatment. The study demonstrated its effectiveness in alleviating symptoms such as pain and bleeding, highlighting its potential as an advanced treatment option.

As cutting-edge technologies continue to emerge, they are transforming traditional treatment approaches, expanding patient access to effective solutions, and fueling market growth.

Regional Analysis

North America remains the dominant player in the global hemorrhoids treatment market, driven by a combination of factors such as a high incidence rate of hemorrhoids, advanced healthcare infrastructure, and increasing demand for minimally invasive treatment options. The region benefits from substantial healthcare expenditure, heightened awareness of hemorrhoidal conditions, and a strong presence of key market players pushing for innovation in treatment solutions. Moreover, favorable reimbursement policies, along with a growing number of outpatient procedures, further contribute to the market's expansion.

Market Segments

1. By Type
   1. Internal
   2. External
   3. Prolapsed
2. By Treatment
   1.  Surgical Intervention
   2.  Rubber band ligation
   3.  Sclerotherapy
   4.  Infrared coagulation
   5.  Hemorrhoidectomy
   6.  Hemorrhoid stapling
   7.  Others
   8. Pharmacological Treatment
3. By End-User
   1. Hospitals
   2. Outpatient facilities  
4. By Regions
   1. North America
   2. Europe
   3. Asia-Pacific
   4. Central & South America
   5. The Middle East and Africa